Assembly Biosciences Inc <ASMB.OQ> expected to post a loss of $1.60 a share - Earnings Preview

• Assembly Biosciences Inc ASMB.OQ ASMB.O is expected to show a rise in quarterly revenue when it reports results on May 6 (estimated) for the period ending March 31 2025

• The South San Francisco California-based company is expected to report a 28.2% increase in revenue to $7.415 million from $5.79 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.

• ​LSEG's mean analyst estimate for Assembly Biosciences Inc is for a loss of $1.60 per share.

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Assembly Biosciences Inc is $35.00​, above​ its last closing price of $11.44. ​​​

This summary was machine generated May 2 at 11:16 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)